SkinEHDLF a hybrid deep learning approach for accurate skin cancer classification in complex systems.

Sci Rep

Department of Information Technology, College of Computers and Information Technology, Taif University, P. O. Box 11099, Taif, 21974, Saudi Arabia.

Published: April 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Skin cancer represents a significant global public health issue, and prompt and precise detection is essential for effective treatment. This study introduces SkinEHDLF, an innovative deep-learning model that enhances skin cancer classification. SkinEHDLF utilizes the advantages of several advanced models, i.e., ConvNeXt, EfficientNetV2, and Swin Transformer, while integrating an adaptive attention-based feature fusion mechanism to enhance the synthesis of acquired features. This hybrid methodology combines ConvNeXt's proficient feature extraction capabilities, EfficientNetV2's scalability, and Swin Transformer's long-range attention mechanisms, resulting in a highly accurate and dependable model. The adaptive attention mechanism dynamically optimizes feature fusion, enabling the model to focus on the most relevant information, enhancing accuracy and reducing false positives. We trained and evaluated SkinEHDLF using the ISIC 2024 dataset, which comprises 401,059 skin lesion images extracted from 3D total-body photography. The dataset is divided into three categories: melanoma, benign lesions, and noncancerous skin anomalies. The findings indicate the superiority of SkinEHDLF compared to current models. In binary skin cancer classification, SkinEHDLF surpassed baseline models, achieving an AUROC of 99.8% and an accuracy of 98.76%. The model attained 98.6% accuracy, 97.9% precision, 97.3% recall, and 99.7% AUROC across all lesion categories in multi-class classification. SkinEHDLF demonstrates a 7.9% enhancement in accuracy and a 28% decrease in false positives, outperforming leading models including ResNet-50, EfficientNet-B3, ViT-B16, and hybrid methodologies such as ResNet-50 + EfficientNet and ViT + CNN, thereby positioning itself as a more precise and reliable solution for automated skin cancer detection. These findings underscore SkinEHDLF's capacity to transform dermatological diagnostics by providing a scalable and accurate method for classifying skin cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12037884PMC
http://dx.doi.org/10.1038/s41598-025-98205-7DOI Listing

Publication Analysis

Top Keywords

skin cancer
24
cancer classification
12
classification skinehdlf
12
skin
8
feature fusion
8
false positives
8
skinehdlf
7
cancer
6
skinehdlf hybrid
4
hybrid deep
4

Similar Publications

Purpose: To clinically validate the nursing diagnosis "Inadequate Nutritional Intake" based on elements identified within a specific situation theory framework in the context of children with cancer.

Methods: This is a diagnostic accuracy study following the Standards for Reporting Diagnostic Accuracy Studies (STARD) protocol. Specifically, it refers to the clinical validation phase of the nursing diagnosis Inadequate nutritional intake, using a cross-sectional design.

View Article and Find Full Text PDF

Dermal Filler Use in Patients Undergoing Chemotherapy and Radiation Therapy.

JMIR Dermatol

September 2025

College of Osteopathic Medicine, Rocky Vista University, 8401 S Chambers Road, Parker, CO, 80112, United States, 1 9253236431.

Dermal fillers have gained increasing popularity for their ability to enhance facial symmetry, restore volume, and improve skin texture. However, their use in patients with cancer undergoing active chemotherapy and radiation therapy poses unique challenges, as these treatments can alter both the safety profile and efficacy of filler procedures. Chemotherapy can interfere with normal wound healing and immune responses, warranting a more cautious and individualized approach when considering dermal fillers in this population.

View Article and Find Full Text PDF

Introduction: Pilots have an increased incidence of cutaneous melanoma compared to the general population; occupational exposure to ultraviolet (UV) radiation is one of several potential risk factors. Cockpit windshields effectively block UVB (280-315 nm) but further analysis is needed for UVA (315-400 nm). The objective of this observational study was to assess transmission of UVA through cockpit windshields and to measure doses of UVA at pilots' skin under daytime flying conditions.

View Article and Find Full Text PDF

Single-cell and spatial transcriptomics identify dihydrolipoic acid succinyltransferase as a promoter of tumor invasion via vascular pathways in cutaneous melanoma.

Int J Biol Macromol

September 2025

School of Life Sciences, Anhui Medical University, Hefei, 230032, China; Translational Research Institute of Henan Provincial People's Hospital, Henan International Joint Laboratory of Non-coding RNA and Metabolism in Cancer, Henan Provincial Key Laboratory of Long Non-coding RNA and Cancer Metaboli

Melanoma is the most aggressive and lethal form of skin cancer, posing significant challenges for prognosis assessment and treatment. Recently, metabolic reprogramming and epigenetic regulation have gained attention for their roles in cancer progression. The role of the key metabolic enzyme dihydrolipoic acid succinyltransferase (DLST) in cancer is currently unclear.

View Article and Find Full Text PDF

Wearable bioelectronics for skin cancer management.

Biomaterials

August 2025

Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, 90095, USA. Electronic address:

Wearable bioelectronics have transformed modern biomedical applications by enabling seamless integration with biological tissues, providing continuous, comprehensive, and personalized healthcare. Skin cancer, particularly melanoma, poses a significant clinical challenge due to its high metastatic potential and associated mortality. Traditional diagnostic approaches face limitations in accuracy, accessibility, and reproducibility, while existing treatments are often constrained by systemic toxicity and therapeutic resistance.

View Article and Find Full Text PDF